|
|
The Progress of Study on Innate Immunity Led to the Design and Development of More Specific and Focused Adjuvants |
SUN Ying-jun, ZHANG Yan, WU Qiong, ZHENG Hai-xue, ZHANG Zhi-dong |
State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Animal Virology of the Ministry of Agriculture, National Foot-and-mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China |
|
|
Abstract Recombinant DNA vaccines, subunit vaccines and synthetic peptide vaccines have sprung up one after another in recent years. These vaccines are characteristic with high purity, specificity, but they can not induce efficient immune response because of small molecule and low immunogenicity. Therefor, there is demand for safe and non-toxic adjuvants able to enhance the protective immune response. Recent advances in basic immunology have elucidated how early innate immune signals can shape subsequent adaptive responses, and this coupled with improvements in biochemical techniques, has led to the design and development of more specific and focused adjuvants.The type and mechanism of adjuvants, the progress of study on innate immunity and also explores future directions of adjuvant development are reviewed. All these could provide some references for the study on highly active, low toxicity adjuvants.
|
Received: 11 November 2010
Published: 01 April 2011
|
|
|
|
[1] Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science, 2010, 327(5963): 291.
[2] Guy B. The perfect mix: Recent progress in adjuvant research.Nature Reviews Microbiology, 2007 , 5(7): 505-517 1740-1526.
[3] Farhat K, Riekenberg S, Heine H, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. Journal of Leukocyte Biology, 2008, 83(3): 692.
[4] Letran S, Lee S, Atif S, et al. TLR5 functions as a scavenger receptor to enhance flagellin-specific CD4 T cell responses. The Journal of Immunology, 2010, 184(Meeting Abstracts 1): 136.
[5] Yarovinsky F, Zhang D, Andersen J, et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science, 2005, 308(5728): 1626.
[6] McCluskie M, Krieg A. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CPG DNA. From Innate Immunity to Immunological Memory, 2006,311:155-178.
[7] Krieg A. Therapeutic potential of Toll-Like receptor 9 activation, Nature Reviews Drug Discovery, 2006, 5(6): 471-484.
[8] Boulard O, Asquith M, Powrie F, et al. TLR2-independent induction and regulation of chronic intestinal inflammation. European Journal of Immunology, 2010, 40(2): 516-524.
[9] Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature, 2006, 442(7098): 39-44.
[10] Fritz J, Le Bourhis L, Sellge G, et al. NOD1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity, 2007, 26(4): 445-459.
[11] Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature , 2006, 441(7089): 101-105.
[12] Akira, S. Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunological Reviews, 2009, 227(1): 5-8.
[13] Robinson M, Sancho D, Slack E, et al. Myeloid c-type lectins in innate immunity. Nature Immunology, 2006, 7(12): 1258-1265.
[14] Klesney-Tait J, Turnbull I, Colonna M. The trem receptor family and signal integration. Nature Immunology, 2006,7(12); 1266-1273.
[15] Coffman R, Sher A, Seder R. Vaccine adjuvants: putting innate immunity to work. Immunity, 2010, 33(4): 492-503.
[16] Fritz J, Girardin S, Fitting C, et al. Synergistic stimulation of human monocytes and dendritic cells by toll-like receptor 4 and NOD1-and NOD2-activating agonists. European Journal of Immunology, 2005, 35(8): 2459-2470.
[17] Petterson T, Jendholm J, Mansson A,et al. Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-Like receptors. Journal of Leukocyte Biology,2011,89(2):177-187. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|